Clinicopathologic and genomic factors impacting efficacy of first-line chemoimmunotherapy in advanced NSCLC Journal Article


Authors: Alessi, J. V.; Elkrief, A.; Ricciuti, B.; Wang, X.; Cortellini, A.; Vaz, V. R.; Lamberti, G.; Frias, R. L.; Venkatraman, D.; Fulgenzi, C. A. M.; Pecci, F.; Recondo, G.; Di Federico, A.; Barrichello, A.; Park, H.; Nishino, M.; Hambelton, G. M.; Egger, J. V.; Ladanyi, M.; Digumarthy, S.; Johnson , B. E.; Christiani, D. C.; Lin, X.; Gainor, J. F.; Lin, J. J.; Pinato, D. J.; Schoenfeld, A. J.; Awad, M. M.
Article Title: Clinicopathologic and genomic factors impacting efficacy of first-line chemoimmunotherapy in advanced NSCLC
Journal Title: Journal of Thoracic Oncology
Volume: 18
Issue: 6
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2023-06-01
Start Page: 731
End Page: 743
Language: English
DOI: 10.1016/j.jtho.2023.01.091
PROVIDER: EBSCOhost
PROVIDER: cinahl
PUBMED: 36775193
PMCID: PMC10500613
DOI/URL:
Notes: Accession Number: 163795142 -- Entry Date: In Process -- Revision Date: 20230522 -- Publication Type: Article -- Journal Subset: Biomedical; Blind Peer Reviewed; Peer Reviewed; USA -- NLM UID: 101274235. -- Source: Cinahl
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Marc Ladanyi
    1329 Ladanyi
  2. Jacklynn V Egger
    69 Egger
  3. Arielle Elkrief
    43 Elkrief